You are here

Article Text

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Genomics, genetics and epigenetics of rheumatic diseases
THU0493 Association of the Toll-Like Receptor 4 (TLR4) Gene with Gout
  1. T. Merriman1,
  2. R. Topless1,
  3. R. Day2,
  4. D. Kannangara2,
  5. K. Williams2,
  6. L. Bradbury3,
  7. M. Brown3,
  8. A. Harrison4,
  9. C. Hill5,
  10. G. Jones6,
  11. S. Lester5,
  12. G. Littlejohn7,
  13. M. Rischmueller5,
  14. B. Shenstone8,
  15. M. Smith5,
  16. M. Andres9,
  17. T. Bardin10,
  18. M. Doherty11,
  19. M. Janssen12,
  20. T. Jansen13,
  21. L. Joosten13,
  22. F. Perez-Ruiz14,
  23. T. Radstake15,
  24. P. Riches16,
  25. E. Roddy17,
  26. A.-K. Tausche18,
  27. L. Stamp19,
  28. N. Dalbeth20,
  29. F. Liote10,
  30. A. So21,
  31. H. Rasheed1
  32. on behalf of Eurogout (European Crystal Network); Arthritis Genomics Initiative in Australasia
  1. 1University of Otago, Dunedin, New Zealand
  2. 2University of New South Wales, Sydney
  3. 3University of Queensland, Brisbane, Australia
  4. 4University of Otago, Wellington, New Zealand
  5. 5The Queen Elizabeth Hospital, Adelaide
  6. 6University of Tasmania, Hobart
  7. 7Monash University, Melbourne
  8. 8Concord Hospital, Concord, Australia
  9. 9Hospital General Universitario de Alicante, Alicante, Spain
  10. 10Université Paris Diderot, Paris, France
  11. 11University of Nottingham, Nottingham, United Kingdom
  12. 12Rijnstate Hospital, Arnhem
  13. 13Radboud University Medical Centre, Nijmegen, Netherlands
  14. 14Cruces University Hospital, Barakaldo, Spain
  15. 15University Medical Center, Utrecht, Netherlands
  16. 16University of Edinburgh, Edinburgh
  17. 17Keele University, Keele, United Kingdom
  18. 18Dresden University, Dresden, Germany
  19. 19University of Otago, Christchurch
  20. 20University of Auckland, Auckland, New Zealand
  21. 21University of Lausanne, Lausanne, Switzerland

Abstract

Background Gout results from innate immune response to monosodium urate (MSU) crystals that form when serum urate is elevated. Identification of genetic risk factors for hyperuricemia and the MSU immune response is therefore important for insight into the etiology of gout. Whilst genome-wide association studies have provided significant insights into the causes of hyperuricemia there are no confirmed loci for non-serum urate pathways in gout. Recently association of the rs2149356 variant in the TLR4 locus with gout was reported in a Chinese sample set (odds ratio TT genotype =1.88, P=8x10–5)1. TLR4 triggers innate immune response to endogenous ligands, including MSU crystals2.

Objectives To test rs2149356 for association in European and New Zealand (NZ) Polynesian gout case-control sample sets.

Methods All gout cases were clinically ascertained according to the American Rheumatism Association criteria. European cases (n=1606) were recruited from New Zealand (n=599), by the Eurogout consortium within the European Crystal Network (n=784) and by the Arthritis Genomics Recruitment Initiative in Australasia (AGRIA; n=223). European non-gouty controls (n=8066) were recruited from NZ (n=875) and sourced from the Atherosclerosis Risk in Communities (n=4144) and Framingham Heart (n=3047) studies. There were 872 New Zealand Maori and Pacific Island (Polynesian) cases and 1088 controls. Genotyping was done by Taqman and statistical analysis by STATA.

Results Using unstratified controls the T allele, but not the TT genotype, was associated with gout in Europeans (ORTallele=1.09, P=0.05; ORTTgenotype=1.15, P=0.13). There was no evidence for association in Polynesians (ORTallele=0.90, P=0.12; ORTTgenotype=0.88, P=0.31). However, comparison of cases to hyperuricemic controls strengthened evidence for association with gout in Europeans (ORTallele=1.18, P=0.004; ORTTgenotype=1.38, P=0.017), but made no difference in Polynesians (ORTallele=, P=0.30; ORTTgenotype=0.87, P=0.47).

Figure

Conclusions The previous report of association of TLR4 with gout in Chinese was replicated in Europeans but not Polynesians. Strengthening of association using hyperuricemic controls is consistent with a role for this locus in gouty inflammation in the presence of hyperuricemia. Subject to further replication, TLR4 represents the first non-serum urate genetic risk locus identified in gout, and provides support for a role of TLR4 in etiology.

References

  1. Qing et al. PLoS One 2013;5:e64845.

  2. Liu-Bryan et al. Arthritis Rheum 2005;52:2936

Disclosure of Interest : None declared

DOI 10.1136/annrheumdis-2014-eular.4781

https://doi.org/10.1136/annrheumdis-2014-eular.4781

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.